Stock Yards Bank & Trust Co. Trims Stock Position in UnitedHealth Group Incorporated $UNH

Stock Yards Bank & Trust Co. lowered its position in shares of UnitedHealth Group Incorporated (NYSE:UNH) by 13.5% in the third quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 65,771 shares of the healthcare conglomerate’s stock after selling 10,225 shares during the period. Stock Yards Bank & Trust Co.’s holdings in UnitedHealth Group were worth $22,711,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Several other hedge funds and other institutional investors also recently added to or reduced their stakes in the business. Brighton Jones LLC lifted its holdings in shares of UnitedHealth Group by 176.2% in the 4th quarter. Brighton Jones LLC now owns 44,249 shares of the healthcare conglomerate’s stock worth $22,384,000 after acquiring an additional 28,231 shares during the last quarter. Revolve Wealth Partners LLC boosted its holdings in UnitedHealth Group by 137.1% during the 4th quarter. Revolve Wealth Partners LLC now owns 4,019 shares of the healthcare conglomerate’s stock valued at $2,033,000 after acquiring an additional 2,324 shares during the period. Exchange Traded Concepts LLC increased its stake in UnitedHealth Group by 48.0% during the second quarter. Exchange Traded Concepts LLC now owns 4,184 shares of the healthcare conglomerate’s stock worth $1,305,000 after purchasing an additional 1,357 shares during the period. Ridgewood Investments LLC boosted its holdings in UnitedHealth Group by 322.3% in the second quarter. Ridgewood Investments LLC now owns 511 shares of the healthcare conglomerate’s stock valued at $159,000 after purchasing an additional 390 shares during the period. Finally, Farmers Trust Co. grew its holdings in UnitedHealth Group by 42.4% during the 2nd quarter. Farmers Trust Co. now owns 2,129 shares of the healthcare conglomerate’s stock worth $664,000 after acquiring an additional 634 shares in the last quarter. Institutional investors and hedge funds own 87.86% of the company’s stock.

UnitedHealth Group Stock Performance

UnitedHealth Group stock opened at $338.47 on Wednesday. The company has a debt-to-equity ratio of 0.71, a current ratio of 0.82 and a quick ratio of 0.82. The company has a market cap of $306.60 billion, a P/E ratio of 17.67, a price-to-earnings-growth ratio of 2.00 and a beta of 0.42. UnitedHealth Group Incorporated has a fifty-two week low of $234.60 and a fifty-two week high of $606.36. The firm’s 50 day simple moving average is $330.76 and its 200-day simple moving average is $322.56.

UnitedHealth Group (NYSE:UNH) last posted its quarterly earnings results on Tuesday, October 28th. The healthcare conglomerate reported $2.92 EPS for the quarter, beating the consensus estimate of $2.87 by $0.05. UnitedHealth Group had a net margin of 4.04% and a return on equity of 19.23%. The business had revenue of $113.16 billion for the quarter, compared to analysts’ expectations of $113.19 billion. During the same period in the previous year, the company posted $7.15 EPS. UnitedHealth Group’s revenue was up 12.2% on a year-over-year basis. As a group, equities research analysts predict that UnitedHealth Group Incorporated will post 29.54 EPS for the current year.

UnitedHealth Group Announces Dividend

The company also recently announced a quarterly dividend, which was paid on Tuesday, December 16th. Investors of record on Monday, December 8th were issued a $2.21 dividend. This represents a $8.84 annualized dividend and a yield of 2.6%. The ex-dividend date was Monday, December 8th. UnitedHealth Group’s dividend payout ratio (DPR) is 46.14%.

Analyst Upgrades and Downgrades

A number of brokerages recently issued reports on UNH. Leerink Partners set a $410.00 price target on UnitedHealth Group and gave the company an “outperform” rating in a report on Wednesday, October 29th. Mizuho upped their target price on shares of UnitedHealth Group from $300.00 to $430.00 and gave the company an “outperform” rating in a report on Thursday, October 9th. Weiss Ratings upgraded UnitedHealth Group from a “sell (d+)” rating to a “hold (c-)” rating in a report on Friday, October 24th. Piper Sandler dropped their price objective on shares of UnitedHealth Group from $423.00 to $417.00 and set an “overweight” rating on the stock in a research note on Tuesday, October 28th. Finally, Royal Bank Of Canada lifted their price target on shares of UnitedHealth Group from $286.00 to $408.00 and gave the stock an “outperform” rating in a research note on Wednesday, October 29th. One investment analyst has rated the stock with a Strong Buy rating, seventeen have assigned a Buy rating, nine have issued a Hold rating and three have assigned a Sell rating to the company. Based on data from MarketBeat.com, the stock has a consensus rating of “Moderate Buy” and an average price target of $385.75.

UnitedHealth Group Company Profile

UnitedHealth Group Inc is a diversified health care company headquartered in Minnetonka, Minnesota, that operates two primary business platforms: UnitedHealthcare and Optum. Founded in 1977, the company provides a broad range of health benefits and health care services to individuals, employers, governmental entities and other organizations. Its operations span commercial employer-sponsored plans, individual and Medicare and Medicaid programs, and services for customers and health systems in the United States and selected international markets.

UnitedHealthcare is the company’s benefits business, administering health plans and networks, managing provider relationships, and offering coverage products for employers, individuals, and government-sponsored programs.